Apcotex Industries (APCOTEXIND) Q3 25/26 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 25/26 earnings summary
2 Feb, 2026Executive summary
Achieved 10% year-on-year volume growth in Q3, with operating revenue declining 7% due to lower prices, but operating EBITDA rose 61% year-on-year to INR 44 crore and PAT increased 91% to INR 22 crore, with a PAT margin of 6.7%.
For the nine months, highest ever sales and export volumes, up 15% and 21% year-on-year, respectively.
Interim dividend of INR 2.50 per share declared for FY 2025-26.
Recognized among Forbes Asia's Best Under A Billion 2023 and received CII award for innovation.
Audited financial results for the quarter and nine months ended December 31, 2025, show continued profitability and operational stability.
Financial highlights
Q3 FY26 operating revenue: INR 332 crore (down 7% year-on-year); EBITDA: INR 44 crore (up 61% year-on-year); PAT: INR 22 crore (up 91% year-on-year); EBITDA margin: 13.12%; PAT margin: 6.7%.
9M FY26 operating revenue: INR 1,044 crore (broadly stable year-on-year); EBITDA: INR 123 crore (up 42% year-on-year); PAT: INR 67 crore (up 79% year-on-year); EBITDA margin: 11.75%; PAT margin: 6.39%.
Net profit margin improved to 6.39% for 9M FY26, up 281 bps YoY.
Debt reduced by INR 94 crore during the nine months.
EPS for Q3 was INR 4.28 (not annualised).
Outlook and guidance
Management expects further margin improvement as capacity utilization increases and product/customer mix optimizes.
EBITDA margins are expected to remain in the 12%-16% range, with potential for further improvement.
Expansion projects are on track, with commissioning expected between late FY26 and early FY27, adding INR 550-600 crore to top line.
Full capacity utilization in nitrile latex and NBR expected within the next year.
The company continues to monitor the impact of new labour codes and will account for any future changes as required.
Latest events from Apcotex Industries
- FY25 revenue reached INR 13,924 Mn, with ongoing capacity expansion and strong industry presence.APCOTEXIND
Investor presentation24 Feb 2026 - Q1 FY25 delivered record revenue and profit growth, with robust volumes and export gains.APCOTEXIND
Q1 24/252 Feb 2026 - Record revenue and export growth in H1 FY25, but margins remain under pressure.APCOTEXIND
Q2 24/2518 Jan 2026 - Record revenue and export growth, but margins compressed; interim dividend and board strengthened.APCOTEXIND
Q3 24/259 Jan 2026 - Strong H1 profit and margin growth, record exports, and major capacity expansion approved.APCOTEXIND
Q2 25/2617 Dec 2025 - FY25 revenue and exports hit records, but profit margins narrowed; Rs. 4.50 dividend proposed.APCOTEXIND
Q4 24/2518 Nov 2025 - Q1 FY26 delivered record sales, export growth, and higher margins, with a new CFO appointed.APCOTEXIND
Q1 25/2616 Nov 2025